Get Live Data

The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses
Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licensesView Video

Latest Share Chat

  2. Share Prices
  3. Arecor Therape Share Price
  4. Arecor Therape Share Regulatory News

Pin to quick picksArecor Therape Regulatory News (AREC)

Arecor Therape Information

Share Price Information for Arecor Therape (AREC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 136.50
Bid: 133.00
Ask: 140.00
Change: 0.00 (0.00%)
Spread: 7.00 (5.263%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 136.50
AREC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

123
Date   Source Headline
23rd Apr 20247:00 amRNSBOARD CHANGE
12th Mar 20248:58 amRNSArecor and TRx Biosciences research collaboration
12th Mar 20247:00 amRNSArecor and TRx Biosciences research collaboration
29th Feb 20247:00 amRNSArecor announces launch of Ogluo® in Netherlands
1st Feb 20247:00 amRNSYear End Trading Update
23rd Jan 20244:58 pmRNSArecor announces update on INBRX-101
18th Jan 20247:00 amRNSArecor granted key European patent
8th Jan 20247:00 amRNSExpansion of specialty hospital collaboration
3rd Jan 20247:00 amRNSAppointment of SVP for Tetris Pharma Ltd
4th Dec 20237:00 amRNSAgreement with global medical products company
29th Nov 20237:00 amRNSArecor Continues Collaboration with Lilly
17th Nov 20237:00 amRNSProduct with Arestat technology launched in Europe
2nd Nov 20237:00 amRNSInhibrx milestone triggers payment to Arecor
1st Nov 20233:31 pmRNSExercise of rollover options & Total Voting Rights
2nd Oct 20237:00 amRNSProgress of Phase I clinical study of AT278
15th Sep 20237:00 amRNSArecor on Investor Meet Company Platform
14th Sep 20237:00 amRNSInterim Results for six months ended 30 June 2023
7th Sep 20237:00 amRNSArecor: positive Hikma FDA pre-IND meeting
4th Sep 20237:00 amRNSTETRIS PHARMA ANNOUNCES AGREEMENT WITH GOODLIFE
17th Aug 20237:00 amRNSCollaboration With Top 10 Global Pharma
10th Aug 20237:00 amRNSNotice of Interim Results
20th Jul 20237:00 amRNSArecor Business Update
5th Jul 20237:00 amRNSAdditional Agreement with Leading Biopharma
27th Jun 20237:00 amRNSArecor granted key patents in Europe and China
26th Jun 20237:00 amRNSArecor presents positive data for AT247 at ADA
9th Jun 20233:35 pmRNSExercise of rollover options & Total Voting Rights
9th Jun 202312:43 pmRNSResult of AGM
9th Jun 20237:00 amRNSAGM Statement
24th May 20237:00 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSTETRIS PHARMA LAUNCHES OGLUO® IN DENMARK & NORWAY
4th May 20234:00 pmRNSARECOR 2022 ANNUAL REPORT AND NOTICE OF AGM
26th Apr 20237:00 amRNSArecor Granted Key U.S Patent
21st Apr 20237:00 amRNSArecor on Investor Meet Company Platform
20th Apr 20237:00 amRNSUnaudited Preliminary Results for 2022
5th Apr 20237:00 amRNSArecor Appoints Chief Business Officer
22nd Mar 20237:00 amRNSFIRST PATIENT DOSED IN AT278 CLINICAL TRIAL
13th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20232:05 pmRNSSecond Price Monitoring Extn
13th Mar 20232:00 pmRNSPrice Monitoring Extension
13th Mar 202311:05 amRNSSecond Price Monitoring Extn
13th Mar 202311:00 amRNSPrice Monitoring Extension
13th Mar 20239:05 amRNSSecond Price Monitoring Extn
13th Mar 20239:00 amRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSARECOR TO PRESENT SHARESOC WEBINAR
24th Feb 20234:44 pmRNSHolding(s) in Company
24th Feb 20237:00 amRNSNotice of Results
16th Feb 20237:00 amRNSArecor Granted Patents in India and the US
14th Feb 20237:01 amRNSARECOR STRENGTHENS COLLABORATION WITH PARTNER
30th Jan 20237:00 amRNSArecor Publishes Data for AT278 in Diabetes Care
19th Jan 20237:00 amRNSBUSINESS UPDATE
123

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.